Researchers have found that a long-acting injection, given just twice a year alongside standard drugs. Blood pressure is one of the most common health problems worldwide, yet it remains difficult to ...

In a study published in the Journal of Extracellular Vesicles, scientists from the UF Health Cancer Institute have found a way to make treatment for a notoriously aggressive breast cancer more ...

When Arinze Nkemdirim Okere, PharmD, MBA, worked as the pharmacist for a hospital in Tallahassee, Florida, he noticed that ...

The study showed some people regain the weight about four times faster than traditional weight loss programs. Officials release billions of gallons of water from California reservoir TSA is leaving ...

Background Antimicrobial resistance (AMR) is a critical public health issue in Bangladesh, exacerbated by the widespread practice of non-prescribed antibiotic dispensing. This study seeks to assess ...

People who abandon popular GLP-1 weight loss medications like Ozempic put weight back on quickly, researchers say. A new report found people who quit programs regained just under one pound per month, ...

Envudeucitinib is now one of at least three medicines poised to offer stiff competition to Sotyktu, an oral medication aiming to challenge standard biologics for psoriasis. So far, the drug hasn’t ...

A good night's sleep might be an additional benefit some gain from taking weight-loss drugs like Ozempic and Zepbound, a new study says. Obese patients with type 2 diabetes are less likely to need a ...

IgG4-related disease is an autoimmune condition in which misfiring B cells attack organs and cause swelling, fibrosis and tumor-like masses. In the past, the disorder has typically been treated ...

This is read by an automated voice. Please report any issues or inconsistencies here. Los Angeles-based clinical-stage biopharmaceutical company Trethera Corp. received a $2.7-million Small Business ...